Chinese Journal of Cancer Research (CJCR; CN: 11-2591/R; Print ISSN: 1000-9604; Online ISSN: 1993-0631) is supervised by China Association of Science and Technology, sponsored by Chinese Anti-Cancer Association, and owned and published by Chinese Journal of Cancer Research Co., Ltd. and Peking University Cancer Hospital & Institute.

CJCR is published bi-monthly in English, and is an international Open Access (OA) journal devoted to the life sciences and medical sciences. It publishes peer-reviewed original articles of basic investigations and clinical observations, reviews and brief communications providing a forum for the recent experimental and clinical advances in cancer research. This journal is indexed in Science Citation Index Expanded (SCIE), PubMed/PubMed Central (PMC), SciSearch, Chemical Abstracts (CA), EMBASE, Chinainfo, CNKI, CSCI, etc.

CJCR encourages submissions from all areas of cancer research. Topics of particular interest include, but are not limited to, cancer prevention, cancer etiology and epidemiology, molecular cell biology, gene diagnosis and gene therapy, tumor pathology, imaging diagnosis of cancer, surgical oncology, medical oncology, radiation oncology, biological therapy of cancer, minimally invasive surgery, molecular targeted therapy for cancer, interventional radiology, as well as early detection, diagnosis and treatment in various cancers.

Authors should submit their manuscripts online at www.cjcrcn.org. However, if you have problems, please contact the Editorial Office at editor@cjcrcn.org.

Journal Impact Factor (2023): 7

Journal Citation Reports ™, Clarivate Analytics

Published by:

Chinese Journal of Cancer Research

Peking University Cancer Hospital & Institute

Address: No. 52, Fucheng Road, Haidian District, Beijing 100142, China.

Tel/Fax: +86-10-88196612

Email: editor@cjcrcn.org